...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The European journal of neuroscience. >Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1
【24h】

Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1

机译：Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Increasing evidence shows a close relationship between Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM). Recently, glucagon-like peptide-1 (GLP-1), a gut incretin hormone, has become a well-established treatment for T2DM and is likely to be involved in treating cognitive impairment. In this mini review, the similarities between AD and T2DM are summarised with the main focus on GLP-1-based therapeutics in AD.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号